AnnexinA5 renders dead tumor cells immunogenic-implications for multimodal cancer therapies

Keyphrases

• Tumor Cells 100%
• Immunogenic 100%
• Multimodal Cancer Therapy 100%
• Annexin A5 100%
• Apoptotic Tumor Cells 54%
• Tumor 36%
• Macrophages 36%
• Syngeneic 18%
• Phagocytosis 18%
• Dead Cells 18%
• Necrotic Cells 18%
• Immune System 9%
• Swift 9%
• Tumor Growth 9%
• Immunogenicity 9%
• Allogeneic 9%
• Chemotherapy 9%
• Gene-deficient Mice 9%
• Metastasis 9%
• Dendritic Cells 9%
• Hyperthermia 9%
• Phospholipids 9%
• Wild Mice 9%
• Irradiation 9%
• Specific Immune Response 9%
• Residual Tumor 9%
• Therapeutic Vaccine 9%
• Interleukin-1β 9%
• Tumor-free 9%
• Apoptotic Cells 9%
• Immunogenic Cell Death 9%
• Activated Macrophages 9%
• Tumor-initiating Cells 9%
• Ionizing Irradiation 9%
• Tumor Protection 9%
• Annexin Family 9%
• Immune Stimulator 9%
• Specific Ligands 9%
• Noninflammatory 9%
• Selective Affinity 9%
• Dying Tumor Cells 9%

Immunology and Microbiology

• Tumor Cell 100%
• Macrophage 55%
• Syngenic 22%
• Phagocytosis 22%
• Dendritic Cell 11%
• Immunogenicity 11%
• Tumor Necrosis Factor 11%
• Interleukin-1 11%
• Immune Response 11%
• Cell Death 11%
• Wild Type Mouse 11%
• Tumor Cell Vaccine 11%
• Cancer Stem Cell 11%
• Immune System 11%

Pharmacology, Toxicology and Pharmaceutical Science

• Malignant Neoplasm 100%
• Neoplasm 100%
• Phosphatidylserine 17%
• Immunogenicity 5%
• Chemotherapy 5%
• Anti-Inflammatory Drug 5%
• Wild Type Mouse 5%
• Immunogenic Cell Death 5%
• Tumor Necrosis Factor 5%
• Tumor Growth 5%
• Hyperthermia 5%
• Tumor Cell Vaccine 5%
• Phospholipid 5%
• Lipocortin 5%